Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Results available

Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

ClinicalTrials.gov ID: NCT00372619

Public ClinicalTrials.gov record NCT00372619. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 4:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy, such as clofarabine and cytarabine, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells. PURPOSE: This phase I/II trial is studying the side effects and best dose of clofarabine when given together with cytarabine and to see how well they work in treating young patients with refractory or relapsed acute myeloid leukemia or acute lymphoblastic leukemia. (Phase I closed to enrollment as of 09/16/09)

Study identification

NCT ID
NCT00372619
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Children's Oncology Group
Network
Enrollment
74 participants

Conditions and interventions

Conditions

Eligibility (public fields only)

Age range
1 Year to 30 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2007 (Type not available)
Primary completion
Aug 2012 (Actual)
Completion
Aug 2012 (Actual)
Last update posted
Jun 5, 2017

2007 – 2012

United States locations

U.S. sites
74
U.S. states
33
U.S. cities
68
Facility City State ZIP Site status
UAB Comprehensive Cancer Center Birmingham Alabama 35294 —
Southern California Permanente Medical Group Downey California 90027 —
Jonathan Jaques Children's Cancer Center at Miller Children's Hospital Long Beach California 90801 —
Children's Hospital Central California Madera California 93638-8762 —
Children's Hospital of Orange County Orange California 92868 —
Rady Children's Hospital - San Diego San Diego California 92123-4282 —
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California 94115 —
Children's Hospital Colorado Center for Cancer and Blood Disorders Aurora Colorado 80045 —
Alfred I. duPont Hospital for Children Wilmington Delaware 19803 —
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington D.C. District of Columbia 20007 —
Children's National Medical Center Washington D.C. District of Columbia 20010-2970 —
Lee Cancer Care of Lee Memorial Health System Fort Myers Florida 33901 —
Nemours Children's Clinic Jacksonville Florida 32207 —
Nemours Children's Clinic - Orlando Orlando Florida 32806 —
Nemours Children's Clinic - Pensacola Pensacola Florida 32504 —
St. Joseph's Cancer Institute at St. Joseph's Hospital Tampa Florida 33607 —
AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus Atlanta Georgia 30322 —
Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center Savannah Georgia 31403-3089 —
Cancer Research Center of Hawaii Honolulu Hawaii 96813 —
University of Illinois Cancer Center Chicago Illinois 60612-7243 —
Children's Memorial Hospital - Chicago Chicago Illinois 60614 —
Simmons Cooper Cancer Institute Springfield Illinois 62794-9677 —
Indiana University Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202-5289 —
St. Vincent Indianapolis Hospital Indianapolis Indiana 46260 —
Kosair Children's Hospital Louisville Kentucky 40232 —
Tulane Cancer Center Office of Clinical Research Alexandria Louisiana 71315-3198 —
CancerCare of Maine at Eastern Maine Medical Center Bangor Maine 04401 —
Alvin and Lois Lapidus Cancer Institute at Sinai Hospital Baltimore Maryland 21215 —
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21231-2410 —
UMASS Memorial Cancer Center - University Campus Worcester Massachusetts 01655 —
C.S. Mott Children's Hospital at University of Michigan Medical Center Ann Arbor Michigan 48109-0286 —
Helen DeVos Children's Hospital at Spectrum Health Grand Rapids Michigan 49503 —
Masonic Cancer Center at University of Minnesota Minneapolis Minnesota 55455 —
Mayo Clinic Cancer Center Rochester Minnesota 55905 —
University of Mississippi Cancer Clinic Jackson Mississippi 39216-4505 —
Ellis Fischel Cancer Center at University of Missouri - Columbia Columbia Missouri 65203 —
Children's Mercy Hospital Kansas City Missouri 64108 —
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis St Louis Missouri 63110 —
CCOP - Nevada Cancer Research Foundation Las Vegas Nevada 89109-2306 —
Hackensack University Medical Center Cancer Center Hackensack New Jersey 07601 —
Overlook Hospital Morristown New Jersey 07962 —
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick New Jersey 08903 —
Newark Beth Israel Medical Center Newark New Jersey 07112 —
St. Joseph's Hospital and Medical Center Paterson New Jersey 07503 —
Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York New York 10032 —
James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester New York 14642 —
SUNY Upstate Medical University Hospital Syracuse New York 13210 —
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill North Carolina 27599-7295 —
Blumenthal Cancer Center at Carolinas Medical Center Charlotte North Carolina 28232-2861 —
Presbyterian Cancer Center at Presbyterian Hospital Charlotte North Carolina 28233-3549 —
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229-3039 —
Rainbow Babies and Children's Hospital Cleveland Ohio 44106-5000 —
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195 —
Nationwide Children's Hospital Columbus Ohio 43205-2696 —
Dayton Children's - Dayton Dayton Ohio 45404-1815 —
Legacy Emanuel Hospital and Health Center and Children's Hospital Portland Oregon 97227 —
Penn State Children's Hospital Hershey Pennsylvania 17033-0850 —
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104-9786 —
Children's Hospital of Pittsburgh of UPMC Pittsburgh Pennsylvania 15213 —
Palmetto Health South Carolina Cancer Center Columbia South Carolina 29203 —
Greenville Hospital Cancer Center Greenville South Carolina 29605 —
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232-6838 —
Driscoll Children's Hospital Corpus Christi Texas 78411 —
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas Texas 75390 —
Cook Children's Medical Center - Fort Worth Fort Worth Texas 76104 —
Baylor University Medical Center - Houston Houston Texas 77030-2399 —
University of Texas Health Science Center at San Antonio San Antonio Texas 78207 —
Primary Children's Medical Center Salt Lake City Utah 84113-1100 —
Children's Hospital of The King's Daughters Norfolk Virginia 23507-1971 —
Carilion Medical Center for Children at Roanoke Community Hospital Roanoke Virginia 24014 —
Children's Hospital and Regional Medical Center - Seattle Seattle Washington 98105 —
Providence Cancer Center at Sacred Heart Medical Center Spokane Washington 99220-2555 —
Marshfield Clinic - Marshfield Center Marshfield Wisconsin 54449 —
Midwest Children's Cancer Center at Children's Hospital of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00372619, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 5, 2017 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00372619 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →